Eli Lilly and Company

Sr. Director - Global Diagnostics Environment

Chester, Maryland, United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals & BiotechnologyIndustries

Position Overview

  • Location Type: Not Specified
  • Job Type: Full time
  • Salary: Not Specified

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

Organization Overview

At Lilly, we serve an extraordinary purpose. We make a difference for people around the globe by discovering, developing and delivering medicines that help them live longer, healthier, more active lives. Not only do we deliver breakthrough medications, but you also can count on us to develop creative solutions to support communities through philanthropy and volunteerism.

Role Overview

The Sr. Director - Global Diagnostics Environment will leverage their deep diagnostic industry understanding to create clear strategic plans for working effectively with pathology and laboratory medicine groups (e.g., societies, consortia, coalitions, etc.) across the globe. In addition, this leader will maintain up-to-date knowledge of the rapidly evolving global diagnostic ecosystem to support key markets in initiative creation and prioritization.

Responsibilities

  • Function as the global expert leader on diagnostic consortia, coalitions, and industry groups across the company.
  • Create and own the strategic approach for working with consortia, coalitions, and industry groups to advance Lilly’s patient identification goals.
  • Lead the engagement of key global diagnostic groups and their leadership to solicit input into and collaboration for Lilly’s diagnostic priorities.
  • Deliver strategic plan for prioritized collaboration across groups, geographies, and BUs to advance Lilly’s goals.
  • Own cross business unit needs assessment and strategy for global pathology and lab conferences to maximize Lilly enterprise investments in presence and education at key meetings.
  • Engage internal colleagues to ensure clarity, awareness, and coordination with important external diagnostic groups.
  • Survey and monitor diagnostic-related industry activity across priority markets to inform Lilly’s external engagements.
  • Present and/or organize Lilly presenters for key global conferences to drive Lilly’s leadership among stakeholders in lab medicine.
  • Consolidate important insights from global diagnostic environment for benefit of internal partners and to inform innovation and launch readiness tactical planning.
  • Collaborate with Scientific Affairs teams for global diagnostic (e.g., Pathology) global thought leader planning and engagement, synchronized cross-functionally and geographically.
  • Actively collaborate with Corporate and Government Affairs teams across Lilly to refine and support Lilly’s external messaging and interactions.
  • Responsible for ensuring Dx Environment solutions are integrated into Innovation and Launch Readiness planning across the company.

Minimum Qualifications

  • Bachelor’s Degree
  • Minimum of 4 years relevant experience working with external partners in Corporate Affairs, External Affairs, and/or Society leadership role or equivalent experience.
  • Qualified applicants must be authorized to work in the United States on a full-time basis. Lilly will not provide support for or sponsor work authorization and/or visas for this role.

Preferred Qualifications

  • 6+ years relevant diagnostic environment experience
  • Advanced degree (e.g., Ph.D. or MS/MBA)
  • Deep understanding of, and strong network within, the diagnostic ecosystem.

Additional Skills and Preferences

  • Outcomes Focus: Demonstrated both a bias for action and focus on results.
  • Problem Solving: Demonstrated ability to appropriately diagnose business problems and create and implement appropriate solutions.
  • Measurement Orientation: Demonstrated

Skills

Diagnostic industry knowledge
Strategic planning
Stakeholder engagement
Global diagnostic ecosystem understanding
Laboratory medicine
Industry collaboration
Leadership in consortia and coalitions

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI